Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ProMIS Neurosciences Inc. (PMN)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 100.0% | 100.0% | 191.1% |
| Gross profit | 0.0% | 0.0% | -91.1% |
| Research and development | 2884.7% | 1176.4% | |
| General and administrative | 1307.7% | 931.4% | 91.1% |
| Depreciation | 1.1% | 10.3% | 0.3% |
| EBITA | -4191.6% | -2106.5% | -190.9% |
| Amortization of intangibles | 0.9% | 1.3% | 0.2% |
| EBIT | -4192.5% | -2107.9% | -191.1% |
| Pre-tax income | -3238.9% | -2489.0% | -191.1% |
| Income taxes | 0.0% | 0.0% | 0.0% |
| Net income | -3238.9% | -2489.0% | -191.1% |
|